Genomics

Dataset Information

0

PolyA+ RNA expression profiles of Drosophila melanogaster male and female brains after treatment with Sodium salicylate, Chlorpromazine, or Trifluoperazine2HCl


ABSTRACT: To explore some of the sex differential responses to drug treatment, we exposed 3 day post-eclosion virgin Drosophila melanogaster (genotype DGRP-900, FlyBase line ID: FBst0028261) to 3 FDA approved drugs and characterized transcript abundance among male and female brains after 24 hours of drug exposure. The 3 tested drugs are water-soluble group N (Nervous system) compounds according to The Anatomical Therapeutic Chemical (ATC) classification system. Two (Chlorpromazine and Trifluoperazine2HCl) are primarily used to treat psychotic disorders, while the third (Sodium salicylate) is used as an analgesic and antipyretic. Following drug treatment, we dissected fly brains, isolated polyA+ RNA and performed high-throughput RNA-Seq analysis. We conducted quantification and statistical analysis of gene expression difference between tested drugs, sexes and their interaction.

ORGANISM(S): Drosophila melanogaster

PROVIDER: GSE81161 | GEO | 2017/04/05

SECONDARY ACCESSION(S): PRJNA320764

REPOSITORIES: GEO

Similar Datasets

2011-12-01 | GSE33817 | GEO
| E-GEOD-33817 | biostudies-arrayexpress
2004-09-24 | GSE1501 | GEO
| E-MTAB-1747 | biostudies-arrayexpress
| E-GEOD-60314 | biostudies-arrayexpress
| PRJNA320764 | ENA
2019-04-17 | GSE129908 | GEO
2021-10-12 | GSE181494 | GEO
2013-08-16 | GSE49631 | GEO
| E-GEOD-49631 | biostudies-arrayexpress